MDGL - Madrigal Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.49B
Enterprise Value 3995.45M
Trailing P/E N/A
Forward P/E 1-11.87
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.26
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-14.97

Trading Information

Stock Price History

Beta (3Y Monthly) 1.91
52-Week Change 3-58.54%
S&P500 52-Week Change 34.11%
52 Week High 3232.40
52 Week Low 382.39
50-Day Moving Average 392.40
200-Day Moving Average 3106.51

Share Statistics

Avg Vol (3 month) 3180.85k
Avg Vol (10 day) 3266.88k
Shares Outstanding 515.43M
Float 6.28M
% Held by Insiders 111.33%
% Held by Institutions 197.08%
Shares Short (Aug 15, 2019) 42.52M
Short Ratio (Aug 15, 2019) 414.97
Short % of Float (Aug 15, 2019) 437.18%
Short % of Shares Outstanding (Aug 15, 2019) 416.35%
Shares Short (prior month Jul 15, 2019) 42.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 235/1
Last Split Date 3Jul 25, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-8.66%
Return on Equity (ttm)-11.61%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -66.5M
Net Income Avi to Common (ttm)-54.77M
Diluted EPS (ttm)-3.57
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)466.4M
Total Cash Per Share (mrq)30.23
Total Debt (mrq)826k
Total Debt/Equity (mrq)0.18
Current Ratio (mrq)38.06
Book Value Per Share (mrq)29.62

Cash Flow Statement

Operating Cash Flow (ttm)-29.52M
Levered Free Cash Flow (ttm)-12.56M